Collegium Pharmaceutical, Inc. announced that effective May 24, 2024, Joe Ciaffoni will step down as President of the Company. Mr. Ciaffoni will serve as a member of the Board of Directors of the Company until the upcoming 2024 Annual Meeting of Shareholders and will not stand for re-election at the meeting. To ensure a seamless transition, Michael Heffernan, founder, former CEO and Chairman of the Board will serve as Interim President until a new CEO is appointed by the Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.82 USD | -1.05% | +0.45% | +9.88% |
May. 13 | Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program | MT |
May. 10 | Needham Downgrades Collegium Pharmaceutical to Hold From Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.88% | 1.11B | |
+38.69% | 728B | |
+34.55% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+16.32% | 244B | |
+7.82% | 207B | |
-5.07% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Collegium Announces President and Board Changes